SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-06-003323
Filing Date
2006-05-09
Accepted
2006-05-09 17:00:42
Documents
6
Period of Report
2006-03-31

Document Format Files

Seq Description Document Type Size
1 ALNYLAM PHARMACEUTICALS, INC. b60594ape10vq.htm 10-Q 375872
2 EX-10.3 AMENDMENT NO. 2 TO ADDENDUM RE: INFLUENZA PROGRAM b60594apexv10w3.txt EX-10.3 7633
3 EX-31.1 SECTION 302 CERTIFICATION OF THE C.E.O. b60594apexv31w1.htm EX-31.1 8479
4 EX-31.2 SECTION 302 CERTIFICATION OF THE C.F.O. b60594apexv31w2.htm EX-31.2 8374
5 EX-32.1 SECTION 906 CERTIFICATION OF THE C.E.O. b60594apexv32w1.htm EX-32.1 3132
6 EX-32.2 SECTION 906 CERTIFICATION OF THE C.F.O. b60594apexv32w2.htm EX-32.2 3117
  Complete submission text file 0000950135-06-003323.txt   408068
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50743 | Film No.: 06821794
SIC: 2834 Pharmaceutical Preparations